News GSK plc

Equities

Market Closed - London S.E. Other stock markets 11:35:03 2024-04-16 am EDT			5-day change	1st Jan Change
1,610 ^GBX	-2.01%		-0.34%	+11.05%

02:16pm	GSK Says US FDA Accepts Meningococcal Vaccine Candidate for Regulatory Review	MT
10:48am	GSK: vaccine accepted for FDA review	CF

GSK Says US FDA Accepts Meningococcal Vaccine Candidate for Regulatory Review	08:16am	MT
GSK : 5-in-1 meningococcal ABCWY vaccine candidate accepted for regulatory review by US FDA - Form 6-K	06:23am	PU
GSK: vaccine accepted for FDA review	04:48am	CF
GSK's latest meningitis vaccine accepted for review by US regulator	04:00am	AN
GSK Says FDA Accepts GSK Meningitis Vaccine Candidate File	02:41am	RE
US FDA Accepts GSK's Meningococcal Disease Vaccine Candidate for Regulatory Review	02:25am	MT
GSK : 5-in-1 meningococcal ABCWY vaccine candidate accepted for regulatory review by US FDA	02:09am	PU
Pfizer RSV shot meets goals in trial of high-risk adults under age 60	Apr. 09	RE
GSK : Barclays sticks Neutral	Apr. 08	ZD
Barclays Lifts GSK PT, Maintains Equalweight Rating	Apr. 08	MT
Wizz Air raised; HSBC cuts Rentokil to 'hold'	Apr. 08	AN
CureVac Says Phase 2 Interim Data Show Multivalent Flu Vaccine Candidate Boosts Antibody Titers	Apr. 04	MT
GSK : Barclays reiterates its Neutral rating	Apr. 04	ZD
CureVac, GSK's Seasonal Flu Shot Shows Efficacy in Phase 1/2 Study	Apr. 04	MT
CureVac, GSK's Seasonal Flu Shot Shows Efficacy in Phase 1/2 Study	Apr. 04	MT
Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs	Apr. 03	RE
GSK : Berenberg gives a Buy rating	Apr. 03	ZD
GSK : Sell rating from JP Morgan	Mar. 28	ZD
U.S. FDA approves Akebia's anemia drug	Mar. 27	RE
WuXi Biologics Reports Solid 2023 Annual Results	Mar. 27	AQ

No results for this search

GSK PLC : 2023 ended on a strong note; medium- to long-term guidance raised

February 02, 2024 at 09:40 am EST